at Zacks.com (Jan 20, 2015)
More on Monsanto's (MON) FQ1 results: Seeds and genomics sales rose 14% to $1.8B, with corn seed and traits net sales up 27% Y/Y to $1.1B, driven by strength in Brazil, Argentina and Mexico. Raises FY13 EPS guidance to $4.30-$4.40 vs. prior $4.18-$4.32 and $4.40 consensus. Raises FY13 free cash flow guidance to $1.8B-$2B. Shares look headed to new 52-week highs, +4.7% premarket.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 19, 2015)
at Zacks.com (Jan 16, 2015)
at Nasdaq.com (Jan 16, 2015)
Monsanto Company (MON): New Analyst Report from Zacks Equity Research - Zacks Equity Research Reportat Zacks.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs